Skip to main content
. 2021 Sep 30;13(10):1966. doi: 10.3390/v13101966

Table 2.

Characteristics of healthy donors and patients with COVID-19, Me (25;75). Cut-off values are given for an appropriate laboratory.

Parameter, Units (Reference Value) Healthy Donors Patients with COVID-19
Moderate (n = 18) Severe (n = 23)
Age 37.0 (32.0;47.0) 62.5 (52.0;70.0) ^ 59.0 (53.0;77.0) ^
CT, % lung damage 40 (32;52) * 60 (48;68) *
CRP, mg/L (0–5.0) 64.9 (39.7;80.1) 71.4 (36.1;109.5)
D-dimer, µg/mL (0–5.0) 0.55 (0.36;1.25) 0.62 (0.40;1.48)
Ferritin, ng/mL (30–400) 372.8 (148.4;901.1) 422.6 (164.5;713.4)
Fibrinogen, g/L (1.9–4.3) 6.0 (4.1;6.4) 6.0 (4.7;7.0)
Troponin I, ng/mL
(0–0.034)
0.006 (0.002;0.014) 0.002 (0.002;0.002)
Procalcitonin, ng/mL
(0–0.5)
0.07 (0.04;0.15) 0.06 (0.05;0.18)
ALT, U/L (0–41) 39.1 (25.2;72.1) 29.0 (23.0;63.5)
AST, U/L (0–40) 46.0 (31.0;80.0) 37.8 (32.0;61.0)
LDH, U/L (135–225) 335 (325;349) 332 (267;410)
Haemoglobin, g/L 139.5 (136.0;148.0) 128.6 (123.0;140.3) 141.2 (127.2;148.8)
RBC, ×1012 5.00 (4.70;5.13) 4.71 (4.07;5.02) 4.71 (4.45;4.91)
Ht, % 43.2 (41.5;46.0) * 38.6 (34.9;42.4) ^ 40.2 (36.8;42.2) ^
Plt, ×109 208 (194;235) 174 (153;212) 195 (130;301)
WBC, ×109 5.8 (5.4;7.7) 5.1 (3.2;7.3) 4.4 (3.5;6.1) ^
Lymphocytes, ×109 1.95 (1.78;2.21) * 1.03 (0.62;1.30) ^ 1.02 (0.75;1.26) ^
Monocytes, ×109 0.58 (0.39;0.71) 0.51 (0.29;0.58) 0.38 (0.24;0.51) ^
Neutrophils, ×109 2.96 (2.78;4.31) 3.53 (1.98;4.65) 3.06 (2.31;3.97)
Eosinophils, ×109 0.11 (0.08;0.23) * 0.02 (0.01;0.03) ^ 0.01 (0;0.04) ^
Basophils, ×109 0.08 (0.06;1.00) * 0.03 (0.02;0.04) ^ 0.01 (0.01;0.04) ^

* p < 0.01, compared severe and moderate COVID-19. ^ p < 0.01, compared with HD.